Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
It has been more than 25 years since an adverse drug reaction (ADR) monitoring agency was first established in China. In the past few years, the National ADR Monitoring System (NADRMS) has developed rapidly in the country. However, this system has not been reviewed in detail in the literature. Our aim was to demonstrate how individual case safety reports (ICSRs) are reported and evaluated and how data quality control is achieved in China. We also aimed to discuss the present status and future of NADRMS. We reviewed the relevant regulations and literature around ADR reporting in China. ADR report collection tools in China have gone through three phases, namely paper-based reporting, software-based reporting using standalone computers, and online reporting. Nowadays the online reporting system plays an important role in China and the number of ADR reports has rapidly increased. NADRMS is similar to most of the ADR reporting systems around the world, but also has its own unique characteristics such as four levels of monitoring agencies. In summary, there is still a long way to go for China to establish a high-level ADR monitoring system to ensure drug safety.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s40264-016-0446-5 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The establishment of an expected concentration reference range for eltrombopag in the individualized treatment of pediatric immune thrombocytopenia.
Front Pharmacol
August 2025
Department of Pharmacy, Beijing Children's Hospital, Capital Medical University, Beijing, China.
Background: Differences in the clinical efficacy and adverse drug reactions (ADRs) of eltrombopag (ELT) in children with immune thrombocytopenia (ITP) may be positively correlated with the serum trough concentration of ELT. Individual pharmacokinetic variations primarily contribute to differences in ELT concentration among individuals. This study is the first to establish an expected concentration reference range for ELT in treating pediatric persistent/chronic ITP (P/CITP) across different age-groups.
View Article and Find Full Text PDFA real-world safety evaluation of new oral anticoagulants in elderly patients: evidence from the Adverse Drug Reaction Monitoring Center of Henan Province.
J Pharm Policy Pract
September 2025
Department of pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China.
Background: The use of new oral anticoagulants (NOACs) is becoming increasingly widespread, but data on their adverse reactions are still incomplete. Further analysis based on data from the Drug Adverse Reaction Center is needed to guide safe clinical use.
Methods: A retrospective analysis was performed on 281 cases of rivaroxaban and 48 cases of dabigatran etexilate-related ADR reported by medical institutions collected by a provincial Food and Drug Administration from 2018 to 2023.
Mineral chemistry and radiological characteristics of syenogranite bearing rare metals mineralization: environmental implications for radiation safety.
Environ Geochem Health
September 2025
Nuclear Materials Authority, P.O. Box 530, Maadi, Cairo, Egypt.
The investigated syenogranite is predominantly enriched in rare metals mineralization. Thorite contains rare earth elements (REEs), and monazite has low Th- concentrations, while Th and Y are found in zircon crystals. These may be attributed to the effect of hydrothermal alteration.
View Article and Find Full Text PDFReal-world experience with the pentaspline pulsed field ablation system: one-year outcomes of the FARADISE registry.
Europace
September 2025
Jessa Hospital, Hasselt, Belgium.
Aims: Clinical studies with protocol-mandated workflow and monitoring have analysed performance of pulsed field ablation (PFA) for treating atrial fibrillation (AF). The FARADISE registry captures global use of the pentaspline PFA catheter in real-world clinical practice with a follow-up of 3 years.
Methods And Results: FARADISE is a prospective, non-randomized, multi-national registry (NCT05501873) that enrolled subjects clinically indicated for ablation using the pentaspline PFA catheter per medical judgement and hospital standard-of-care.
Improving large language models for adverse drug reactions named entity recognition via error correction prompt engineering.
J Biomed Inform
August 2025
School of Electronic and Electrical Engineering, Shanghai University of Engineering Science, Shanghai 201620, China. Electronic address:
The monitoring and analysis of adverse drug reactions (ADRs ) are important for ensuring patient safety and improving treatment outcomes. Accurate identification of drug names, drug components, and ADR entities during named entity recognition (NER) processes is essential for ensuring drug safety and advancing the integration of drug information. Given that existing medical name entity recognition technologies rely on large amounts of manually annotated data for training, they are often less effective when applied to adverse drug reactions due to significant data variability and the high similarity between drug names.
View Article and Find Full Text PDF